CYLD: a tumor suppressor deubiquitinase regulating NF-κB activation and diverse biological processes

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Cell Death and Differentiation

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/cdd.2009.43PMID 19373246PMCID PMC5848464
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Down-regulation of CYLD expression by Snail promotes tumor progression in malignant melanoma

  2009cited by this paper
• ABIN-1 is a ubiquitin sensor that restricts cell death and sustains embryonic development

  2009cited by this paper
• Essential Role of Sequestosome 1/p62 in Regulating Accumulation of Lys63-ubiquitinated Proteins*

  2008cited by this paper
• The RING Domain and First Zinc Finger of TRAF6 Coordinate Signaling by Interleukin-1, Lipopolysaccharide, and RANKL*

  2008cited by this paper
• ABIN-1 is a Ubiquitin Sensor that Restricts Cell Death and Sustains Embryonic Development

  2008cited by this paper
• Deubiquitylation and regulation of the immune response

  2008influential reference
• Tumor Suppressor Cylindromatosis Acts as a Negative Regulator for Streptococcus pneumoniae-induced NFAT Signaling*

  2008influential reference
• CYLD is a crucial negative regulator of innate immune response in Escherichia coli pneumonia

  2008cited by this paper
• New insights into NF-kappaB regulation and function.

  2008influential reference
• Cutting Edge: K63-Linked Polyubiquitination of NEMO Modulates TLR Signaling and Inflammation In Vivo1

  2008cited by this paper
• Ubiquitin binding mediates the NF-κB inhibitory potential of ABIN proteins

  2008cited by this paper
• The structure of the CYLD USP domain explains its specificity for Lys63-linked polyubiquitin and reveals a B box module.

  2008influential reference
• Inflammatory cardiac valvulitis in TAX1BP1‐deficient mice through selective NF‐κB activation

  2008cited by this paper
• Lys63-Linked Polyubiquitination of IRAK-1 Is Required for Interleukin-1 Receptor- and Toll-Like Receptor-Mediated NF-κB Activation

  2008influential reference
• c-IAP1 and c-IAP2 Are Critical Mediators of Tumor Necrosis Factor α (TNFα)-induced NF-κB Activation*

  2008cited by this paper
• Regulation of IκB Kinase-related Kinases and Antiviral Responses by Tumor Suppressor CYLD*

  2008cited by this paper
• Capturing protein tails by CAP-Gly domains.

  2008cited by this paper
• The tumour suppressor CYLD is a negative regulator of RIG‐I‐mediated antiviral response

  2008influential reference
• The Tumor Suppressor CYLD Regulates Microtubule Dynamics and Plays a Role in Cell Migration*

  2008influential reference
• Deubiquitinating enzyme CYLD negatively regulates RANK signaling and osteoclastogenesis in mice.

  2008cited by this paper
• Bone Remodeling

  2008cited by this paper
• Tumor suppressor CYLD: negative regulation of NF-κB signaling and more

  2008cited by this paper
• CYLD mutations in familial skin appendage tumours

  2008cited by this paper
• Potential role of CYLD (Cylindromatosis) as a deubiquitinating enzyme in vascular cells.

  2008cited by this paper
• TRAF6 Autoubiquitination-Independent Activation of the NFκB and MAPK Pathways in Response to IL-1 and RANKL

  2008cited by this paper
• Inactivation of the CYLD deubiquitinase by HPV E6 mediates hypoxia-induced NF-kappaB activation.

  2008cited by this paper
• Polo on the Rise-from Mitotic Entry to Cytokinesis with Plk1.

  2008cited by this paper
• Tumor suppressor CYLD regulates acute lung injury in lethal Streptococcus pneumoniae infections.

  2007cited by this paper
• HPV E6, E6AP and cervical cancer

  2007cited by this paper
• Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma.

  2007influential reference
• Regulation of B cell homeostasis and activation by the tumor suppressor gene CYLD

  2007influential reference
• Ubiquitin-mediated activation of TAK1 and IKK

  2007cited by this paper
• Tumor Suppressor CYLD Acts as a Negative Regulator for Non-Typeable Haemophilus influenza-Induced Inflammation in the Middle Ear and Lung of Mice

  2007cited by this paper
• Gene mapping and expression analysis of 16q loss of heterozygosity identifies WWOX and CYLD as being important in determining clinical outcome in multiple myeloma.

  2007cited by this paper
• Deubiquitinating enzyme CYLD negatively regulates the ubiquitin-dependent kinase Tak1 and prevents abnormal T cell responses

  2007influential reference
• Deubiquitinating Enzyme CYLD Regulates the Peripheral Development and Naive Phenotype Maintenance of B Cells*♦

  2007cited by this paper
• TRAF6 ubiquitin ligase is essential for RANKL signaling and osteoclast differentiation.

  2007cited by this paper
• IkappaB kinase beta phosphorylates the K63 deubiquitinase A20 to cause feedback inhibition of the NF-kappaB pathway.

  2007influential reference
• Regulation of early wave of germ cell apoptosis and spermatogenesis by deubiquitinating enzyme CYLD.

  2007cited by this paper
• Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma.

  2007influential reference
• Essential role for TAX1BP1 in the termination of TNF-alpha-, IL-1- and LPS-mediated NF-kappaB and JNK signaling.

  2007cited by this paper
• The tumor suppressor CYLD regulates entry into mitosis

  2007influential reference
• Cylindromatosis and the CYLD gene: new lessons on the molecular principles of epithelial growth control

  2007cited by this paper
• Reduced expression of CYLD in human colon and hepatocellular carcinomas.

  2007cited by this paper
• Essential role for TAX1BP1 in the termination of TNF‐α‐, IL‐1‐ and LPS‐mediated NF‐κB and JNK signaling

  2007cited by this paper
• IκB Kinase β Phosphorylates the K63 Deubiquitinase A20 To Cause Feedback Inhibition of the NF-κB Pathway

  2007cited by this paper
• TRPA1 is a substrate for de-ubiquitination by the tumor suppressor CYLD.

  2006cited by this paper
• Regulation of T cell development by the deubiquitinating enzyme CYLD

  2006cited by this paper
• Activation of IKK by TNFalpha requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO.

  2006cited by this paper
• Mechanisms of Disease: genetics of Paget's disease of bone and related disorders

  2006cited by this paper
• Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-kappaB signaling.

  2006cited by this paper
• Ubiquitination of RIP Is Required for Tumor Necrosis Factor α-induced NF-κB Activation*

  2006cited by this paper
• Ubiquitination of RIP is required for tumor necrosis factor alpha-induced NF-kappaB activation.

  2006cited by this paper
• Faculty Opinions recommendation of Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-kappaB signaling.

  2006cited by this paper
• Bone Remodeling

  2006cited by this paper
• Impaired regulation of NF-kappaB and increased susceptibility to colitis-associated tumorigenesis in CYLD-deficient mice.

  2006influential reference
• Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-κB activation

  2006cited by this paper
• ABIN-1 Binds to NEMO/IKKγ and Co-operates with A20 in Inhibiting NF-κB*

  2006cited by this paper
• ABIN-1 binds to NEMO/IKKgamma and co-operates with A20 in inhibiting NF-kappaB.

  2006cited by this paper
• Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-kappaB activation [corrected].

  2006cited by this paper
• The BRG1- and hBRM-Associated Factor BAF57 Induces Apoptosis by Stimulating Expression of the Cylindromatosis Tumor Suppressor Gene

  2005cited by this paper
• Regulation of the Deubiquitinating Enzyme CYLD by IκB Kinase Gamma-Dependent Phosphorylation

  2005influential reference
• Specificity and versatility of SH3 and other proline-recognition domains: structural basis and implications for cellular signal transduction.

  2005cited by this paper
• A20 inhibits NF-kappaB activation by dual ubiquitin-editing functions.

  2005cited by this paper
• Immunity by ubiquitylation: a reversible process of modification

  2005cited by this paper
• Ubiquitin signalling in the NF-kappaB pathway.

  2005cited by this paper
• Dissection of the Inflammatory Bowel Disease Transcriptome Using Genome-Wide cDNA Microarrays

  2005cited by this paper
• A genomic and functional inventory of deubiquitinating enzymes.

  2005cited by this paper
• A20 inhibits NF-κB activation by dual ubiquitin-editing functions

  2005cited by this paper
• Genetics of skin appendage neoplasms and related syndromes

  2005cited by this paper
• Ubiquitin signalling in the NF-κB pathway

  2005cited by this paper
• The Tumor Suppressor Cylindromatosis (CYLD) Acts as a Negative Regulator for Toll-like Receptor 2 Signaling via Negative Cross-talk with TRAF6 and TRAF7*

  2005cited by this paper
• NF-κB Is Essential for Induction of CYLD, the Negative Regulator of NF-κB

  2004cited by this paper
• NF-kappaB is essential for induction of CYLD, the negative regulator of NF-kappaB: evidence for a novel inducible autoregulatory feedback pathway.

  2004influential reference
• SQSTM1 and Paget’s Disease of Bone

  2004cited by this paper
• Bcl10 activates the NF-κB pathway through ubiquitination of NEMO

  2004cited by this paper
• The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses

  2004cited by this paper
• De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling

  2004cited by this paper
• The CAP-Gly domain of CYLD associates with the proline-rich sequence in NEMO/IKKgamma.

  2004influential reference
• Conventional and array-based comparative genomic hybridization analyses of novel cell lines harboring HPV18 from glassy cell carcinoma of the uterine cervix.

  2004cited by this paper
• The world isn't flat.

  2004cited by this paper
• Faculty Opinions recommendation of De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling.

  2004influential reference
• Most dysplasia in ulcerative colitis is visible at colonoscopy.

  2004cited by this paper
• Negative Regulation of JNK Signaling by the Tumor Suppressor CYLD*

  2004cited by this paper
• The Crohn's disease protein, NOD2, requires RIP2 in order to induce ubiquitinylation of a novel site on NEMO.

  2004cited by this paper
• Sequestosome 1/p62 Is a Polyubiquitin Chain Binding Protein Involved in Ubiquitin Proteasome Degradation

  2004cited by this paper
• Analysis of DNA copy number aberrations in hepatitis C virus-associated hepatocellular carcinomas by conventional CGH and array CGH

  2004cited by this paper
• Bcl10 activates the NF-kappaB pathway through ubiquitination of NEMO.

  2004cited by this paper
• Faculty Opinions recommendation of Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB.

  2003cited by this paper
• CYLD is a deubiquitinating enzyme that negatively regulates NF-κB activation by TNFR family members

  2003cited by this paper
• Faculty Opinions recommendation of CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members.

  2003cited by this paper
• The Tumor Suppressor CYLD Interacts with TRIP and Regulates Negatively Nuclear Factor κB Activation by Tumor Necrosis Factor

  2003cited by this paper
• The tumour suppressor CYLD negatively regulates NF-κB signalling by deubiquitination

  2003influential reference
• Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κB

  2003cited by this paper
• Spiradenocylindroma of the Kidney: Clinical and Genetic Findings Suggesting a Role of Somatic Mutation of the CYLD1 Gene in the Oncogenesis of an Unusual Renal Neoplasm

  2002cited by this paper
• Germ cell suicide: new insights into apoptosis during spermatogenesis

  2000cited by this paper
• Identification of the familial cylindromatosis tumour-suppressor gene

  2000influential reference
• A20 and A20-binding proteins as cellular inhibitors of nuclear factor-kappa B-dependent gene expression and apoptosis.

  2000cited by this paper
• Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice.

  2000influential reference
• The modulation of sperm function by fertilization promoting peptide.

  1998cited by this paper

• CYLD Limits Neutrophil-Driven Psoriatic Inflammation

  2026cites this paper
• Case Report: CYLD cutaneous syndrome with malignant transformation to spiradenocarcinoma: cooperative effects of CYLD truncation and an MSH2 clamp-domain variant in an Ecuadorian patient.

  2026cites this paper
• The Potential Role of Deubiquitinating Enzymes (DUBs) in Male Fertility.

  2026cites this paper
• Gut microbiota immaturity with DL-endopeptidase deficiency links antibiotic use to preterm late-onset sepsis.

  2026cites this paper
• Cleavage-Resistant CYLD Protects Against Autoimmune Hepatitis.

  2026cites this paper
• CYLD links the TRAF6/sNASP axis to TLR4 signaling in sepsis-induced acute lung injury

  2025cites this paper
• Chromatin-associated cullin-RING E3 ubiquitin ligases: keeping transcriptionally active NF-κB in check

  2025cites this paper
• Evolutionary analysis and immune-induced expression and m6A modification of RIPK1 and RIPK2 in the miiuy croaker.

  2025cites this paper
• Porcine epidemic diarrhea coronavirus infection activates caspase-8 to enhance innate immunity by blocking CYLD-mediated deubiquitination of RIG-I.

  2025cites this paper
• FABP5 is a key player in metabolic modulation and NF-κB dependent inflammation driving pleural mesothelioma

  2025cites this paper
• Ebola virus VP35 NNLNS motif modulates viral RNA synthesis and MIB2-mediated signaling

  2025cites this paper
• AKT and DUBs: a bidirectional relationship

  2025cites this paper
• Systematic Discovery of Motif-based Interactions of the Auxiliary Domains of USP Family Deubiquitinases

  2025cites this paper
• E2 conjugating enzymes: A silent but crucial player in Ubiquitin Biology.

  2025cites this paper
• Metastatic malignant cylindroma arising on a background of digenic inheritance of BRCA2 and CYLD pathogenic variants targeted with PARP inhibition.

  2025cites this paper
• MALT1 Inhibitors and Degraders: Strategies for NF-κB-Driven Malignancies.

  2025cites this paper
• Compound 3a attenuates myocardial ischemia-reperfusion injury by inhibiting IKK β -dependent oxidative stress

  2025cites this paper
• CYLD-mutated anal squamous cell carcinoma: an uncommon entity associated with cylindroma-like morphology and adverse clinical features.

  2025cites this paper
• CYLD suppresses LPS-induced inflammation through RIP1 deubiquitination in rainbow trout.

  2025cites this paper
• The deubiquitinase OTULIN regulates tau expression and RNA metabolism in neurons

  2025cites this paper
• Multiple Scalp and Neck Lesions in an 80‐Year‐Old Man

  2025cites this paper
• The Ubiquitin–Proteasome System in Asthma: Mechanisms and Therapeutic Possibilities

  2025cites this paper
• Molecular regulation by ubiquitin-specific proteases (USPs) in HCC: cell cycle, oncogenic signaling, and beyond

  2025cites this paper
• TRAF2 regulates the progression of pulmonary fibrosis through β-catenin-Snail signaling pathway

  2025cites this paper
• CYLD suppresses infectious Bursal disease virus replication by deubiquitinating VP1.

  2025cites this paper
• The CYLD–PARP1 feedback loop regulates DNA damage repair and chemosensitivity in breast cancer cells

  2024cites this paper
• The TRIF‐RIPK1‐Caspase‐8 signalling in the regulation of TLR4‐driven gene expression

  2024cites this paper
• Ubiquitin‐Proteasome System in Periodontitis: Mechanisms and Clinical Implications

  2024cites this paper
• Deciphering the Mechanistic Impact of Acupuncture on the Neurovascular Unit in Acute Ischemic Stroke: Insights From Basic Research in a Narrative Review.

  2024cites this paper
• Targeting Ubiquitin-Proteasome System (UPS) in Treating Osteoarthritis.

  2024cites this paper
• Influenza A virus infection activates caspase-8 to enhance innate antiviral immunity by cleaving CYLD and blocking TAK1 and RIG-I deubiquitination

  2024cites this paper
• Cylindromatosis lysine 63 deubiquitinase (CYLD) suppress TLR3-mediated CCL5 expression in human renal proximal tubular epithelial cells

  2024cites this paper
• Research progress of the Otubains subfamily in hepatocellular carcinoma.

  2024cites this paper
• UBE2N is essential for maintenance of skin homeostasis and suppression of inflammation.

  2024cites this paper
• Deubiquitinating enzymes: potential regulators of the tumor microenvironment and implications for immune evasion

  2024cites this paper
• Dysregulation of deubiquitinases in gastric cancer progression

  2024cites this paper
• Grading Challenges and Prognostic Insights in Chromophobe Renal Cell Carcinoma: A Retrospective Study of 72 Patients

  2024cites this paper
• Inactivation of the Tumor Suppressor CYLD Sensitizes Mice to Breast Cancer Development

  2024cites this paper
• CYLD regulates cell ferroptosis through Hippo/YAP signaling in prostate cancer progression

  2024cites this paper
• Cross-regulation of Listeria monocytogenes and the host ubiquitin system in listeriosis.

  2024cites this paper
• The molecular mechanism of NF-κB dysregulation across different subtypes of renal cell carcinoma

  2024cites this paper
• Current State of Melanoma Therapy and Next Steps: Battling Therapeutic Resistance

  2024cites this paper
• From periphery to center stage: 50 years of advancements in innate immunity

  2024cites this paper
• Eccrine Spiradenoma

  2024cites this paper
• cIAP-2 protein is upregulated by human papillomavirus in oropharyngeal cancers: role in radioresistance in vitro

  2024cites this paper
• CYLD in health and disease

  2023cites this paper
• Multiple brain regions are involved in reaction to acute restraint stress in CYLD-knockout mice

  2023cites this paper
• Exploration of gastric carcinogenesis from the relationship between bile acids and intestinal metaplasia and intragastric microorganisms (H. pylori and non-H. pylori)

  2023influential citation
• MicroRNA-425: A Pivotal Regulator Participating in Tumorigenesis of Human Cancers

  2023cites this paper
• Expanding CYLD protein in NF-κβ/TNF-α signaling pathway in response to Lactobacillus acidophilus in non-metastatic rectal cancer patients

  2023cites this paper
• Processing stimulus dynamics by the NF-κB network in single cells

  2023cites this paper
• YTHDC2 Retards Cell Proliferation and Triggers Apoptosis in Papillary Thyroid Cancer by Regulating CYLD-Mediated Inactivation of Akt Signaling

  2023cites this paper
• A computational approach for structural and functional analyses of disease-associated mutations in the human CYLD gene

  2023cites this paper
• Regulation mechanisms of CARMA1–Bcl10–MALT1 complex assembly inferred from the analysis of TRAF6‐deficient cells

  2023cites this paper
• Deubiquitination complex platform: A plausible mechanism for regulating the substrate specificity of deubiquitinating enzymes

  2023cites this paper
• CYLD inhibits osteoclastogenesis to ameliorate alveolar bone loss in mice with periodontitis

  2023cites this paper
• MiR-182-5p Is Upregulated in Hepatic Tissues from a Diet-Induced NAFLD/NASH/HCC C57BL/6J Mouse Model and Modulates Cyld and Foxo1 Expression

  2023cites this paper
• UBE2N is essential for maintenance of skin homeostasis and suppression of inflammation

  2023cites this paper
• The Potential of Cylindromatosis (CYLD) as a Therapeutic Target in Oxidative Stress-Associated Pathologies: A Comprehensive Evaluation

  2023cites this paper
• Omics approaches to better understand the molecular mechanism of necroptosis and their translational implications.

  2023cites this paper
• Ubiquitin-specific proteases: Vital regulatory molecules in bone and bone-related diseases.

  2023cites this paper
• Marine natural product lepadin A as a novel inducer of immunogenic cell death via CD91-dependent pathway

  2023cites this paper
• DUBing Primary Tumors of the Central Nervous System: Regulatory Roles of Deubiquitinases

  2023cites this paper
• Regulation of apoptosis by ubiquitination in liver cancer.

  2023cites this paper
• Characterization of cancer subtypes associated with clinical outcomes by multi-omics integrative clustering

  2023cites this paper
• Wnt/β‑catenin signaling is a novel therapeutic target for tumor suppressor CYLD‑silenced glioblastoma cells.

  2023cites this paper
• Implications of a Neuronal Receptor Family, Metabotropic Glutamate Receptors, in Cancer Development and Progression

  2022cites this paper
• Genotoxicity-Stimulated and CYLD-Driven Malignant Transformation

  2022cites this paper
• Role of pyroptosis in inflammation and cancer

  2022cites this paper
• CYLD variants identified in Alzheimer's disease and frontotemporal dementia patients

  2022cites this paper
• The role of MARCH9 in colorectal cancer progression

  2022cites this paper
• Five-lipoxygenase-activating protein-mediated CYLD attenuation is a candidate driver in hepatic malignant lesion

  2022cites this paper
• Spata2L Suppresses TLR4 Signaling by Promoting CYLD-Mediated Deubiquitination of TRAF6 and TAK1

  2022cites this paper
• CYLD expression in endometrial carcinoma and correlation with clinicohistopathological parameters.

  2022cites this paper
• Emerging Roles of Non-proteolytic Ubiquitination in Tumorigenesis

  2022cites this paper
• The role of miRNAs as a big master regulator of signaling pathways involved in lymphoblastic leukemia

  2022cites this paper
• Deubiquitinase CYLD acts as a negative regulator of dopamine neuron survival in Parkinson’s disease

  2022cites this paper
• Characterization of tumor suppressor CYLD expression in clear cell renal cell carcinoma

  2022influential citation
• Post-translational modification of MALT1 and its role in B cell- and T cell-related diseases.

  2022cites this paper
• Hepatocyte Bcl-3 protects from death-receptor mediated apoptosis and subsequent acute liver failure

  2022cites this paper
• Structures, functions, and inhibitors of LUBAC and its related diseases

  2022cites this paper
• Potential use of EGFR-targeted molecular therapies for tumor suppressor CYLD-negative and poor prognosis oral squamous cell carcinoma with chemoresistance

  2022cites this paper
• Biological implications and clinical potential of invasion and migration related miRNAs in glioma

  2022cites this paper
• Proteomics separates adult-type diffuse high-grade gliomas in metabolic subgroups independent of 1p/19q codeletion and across IDH mutational status

  2022cites this paper
• Pro-apoptotic and anti-apoptotic regulation mediated by deubiquitinating enzymes

  2022cites this paper
• Ubiquitin-specific proteases in inflammatory bowel disease-related signalling pathway regulation

  2022cites this paper
• Pathogenic signaling in multiple myeloma.

  2022cites this paper
• Genetics of Immune Dysregulation and Cancer Predisposition: Two Sides of the Same Coin

  2022cites this paper
• Possibilities of Photodynamic Therapy in the Treatment of Multiple Cylindroma of the Scalp: The Clinical Case Study

  2022cites this paper
• Interactions of a Long Noncoding RNA with Domains of NF-κB and IκBα: Implications for the Inhibition of Non-Signal-Related Phosphorylation.

  2022cites this paper
• Hepatocyte Bcl-3 protects from death-receptor mediated apoptosis and subsequent acute liver failure

  2022cites this paper
• Transforming Growth Factor-β Activated Kinase 1 (Tak1) Is Activated in Hepatocellular Carcinoma, Mediates Tumor Progression, and Predicts Unfavorable Outcome

  2022cites this paper
• Macrophage-Derived Small Extracellular Vesicles in Multiple Diseases: Biogenesis, Function, and Therapeutic Applications

  2022cites this paper
• Exosomal microRNA-588 from M2 polarized macrophages contributes to cisplatin resistance of gastric cancer cells

  2021cites this paper
• Membrane protein-chimeric liposome-mediated delivery of triptolide for targeted hepatocellular carcinoma therapy

  2021cites this paper
• CYLD in Hematological Malignancies

  2021cites this paper
• Down-regulated MicroRNAs in Gastric Carcinoma May Be Targets for Therapeutic Intervention and Replacement Therapy

  2021cites this paper
• Roles and Mechanisms of Deubiquitinases (DUBs) in Breast Cancer Progression and Targeted Drug Discovery

  2021cites this paper
• SMYD2‐mediated TRAF2 methylation promotes the NF‐κB signaling pathways in inflammatory diseases

  2021cites this paper
• TRIM15 and CYLD regulate ERK activation via lysine 63-linked polyubiquitination

  2021cites this paper